Market Place
Sourcing Support
Top drugs and pharmaceutical companies of 2019 by revenues
Acquisitions and spin-offs dominated headlines in 2019 and the tone was set very early with Bristol-
Seven of your facilities are out of compliance, FDA tells Wockhardt; Mylan’s EpiPen sales crash
In Phispers this week, there is news on how alternatives to Mylan’s EpiPen have eaten into it
